Taro Pharmaceuticals U.S.A., Inc. recalls Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For
Taro Pharmaceuticals recalls two strengths of 0.05% clobetasol propionate cream due to failed content uniformity in the manufacturing process. This may affect medication accuracy for skin conditions.
Lower-risk recall
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Contact the company & request your remedy
What happened, in plain English
Taro Pharmaceuticals is recalling two strengths of 0.05% clobetasol propionate cream because the manufacturing process produced batches with inconsistent medication content. This could lead to incorrect dosing for skin conditions. Read more at govinfonow.com/recall/36924-taro-clobetasol-cream-recall-failed-content-uniformity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36924-taro-clobetasol-cream-recall-failed-content-uniformity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1496-2020
Cite this page
“Taro Clobetasol Cream Recall: Failed Content Uniformity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36924-taro-clobetasol-cream-recall-failed-content-uniformity-risk. Based on FDA recall #D-1496-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1496-2020%22&limit=1).
Why it’s dangerous
The manufacturing process produced batches with inconsistent medication content. This means the actual amount of active ingredient may vary, potentially leading to incorrect dosing for skin conditions. However, the risk of serious harm is low as this is a prescription medication used for external application.
Who’s affected
People with prescriptions for this cream, particularly those using it for skin conditions like eczema or psoriasis. Those with sensitive skin may be at higher risk due to potential dosing inaccuracies.
How to tell if you have this one
Check for 15g or 45g tubes labeled 'Clobetasol Propionate Cream USP 0.05%' with NDC numbers 60429-902-15 or 60429-902-45. These were manufactured by Taro Pharmaceuticals and distributed by Golden State Medical Supply.
- Brand
Taro Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC numbers 60429-902-15 or 60429-902-45 on the tube label.
Questions people ask
Is this cream safe to use?
The recall is due to manufacturing inconsistencies, but the cream is still safe for external use. Consult your doctor if you have concerns about dosing.
How do I know if I have the recalled product?
Check for the NDC numbers 60429-902-15 or 60429-902-45 on the tube label.
What should I do if I have the recalled product?
The recall does not require immediate action, but you should check with your doctor or pharmacist about whether to continue using the product.
Contact Taro Pharmaceuticals
We’ve drafted a message you can send Taro Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1496-2020 — Taro Pharmaceuticals Taro Pharmaceuticals Hello, I own a Taro Pharmaceuticals that is covered by recall D-1496-2020 from Taro Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1496-2020 (July 20, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1496-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.